We are live on ! Find out more
MCM

Moore Capital Management Portfolio holdings

AUM $4.92B
1-Year Est. Return 35.41%
This Fund
S&P 500
This Quarter Est. Return
+15.66%
1 Year Est. Return
+35.41%
3 Year Est. Return
+169.06%
5 Year Est. Return
+282.2%
10 Year Est. Return
+2,041.62%
AUM
$5.81B
AUM Growth
+$1.07B
Cap. Flow
+$559M
Cap. Flow %
9.61%
Top 10 Hldgs %
42.43%
Holding
662
New
179
Increased
52
Reduced
73
Closed
154

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$156M
2
MSFT icon
Microsoft
MSFT
+$146M
3
EWZ icon
iShares MSCI Brazil ETF
EWZ
+$76M
4
CRH icon
CRH
CRH
+$74.1M
5
WDAY icon
Workday
WDAY
+$57.8M

Top Sells

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$223M
2
NVDA icon
NVIDIA
NVDA
+$175M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$68.4M
4
SEDG icon
SolarEdge
SEDG
+$37.5M
5
GE icon
GE Aerospace
GE
+$28.8M

Sector Composition

Rank Sector Weight
1 Technology 22.59%
2 Financials 13.94%
3 Consumer Discretionary 8.23%
4 Communication Services 5.67%
5 Industrials 5.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HLMN icon
301
Hillman Solutions
HLMN
$1.54B
$901K 0.02%
100,000
-50,000
-33% -$417K
PHAT icon
302
Phathom Pharmaceuticals
PHAT
$708M
$859K 0.01%
+60,000
New +$692K
CYTK icon
303
Cytokinetics
CYTK
$10.5B
$816K 0.01%
25,000
– –
MRNS
304
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$815K 0.01%
+75,000
New +$642K
RCUS icon
305
Arcus Biosciences
RCUS
$3.55B
$812K 0.01%
+40,000
New +$762K
STVN icon
306
Stevanato
STVN
$5.42B
$777K 0.01%
24,000
– –
KDNY
307
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$768K 0.01%
+20,000
New +$514K
ROIV icon
308
Roivant Sciences
ROIV
$24.5B
$756K 0.01%
+75,000
New +$671K
VYX icon
309
NCR Voyix
VYX
$1.14B
$756K 0.01%
+48,900
New +$706K
NEE icon
310
NextEra Energy
NEE
$181B
$749K 0.01%
+10,100
New +$765K
RNW icon
311
ReNew
RNW
$2.27B
$739K 0.01%
134,903
– –
KOD icon
312
PUT
Kodiak Sciences
KOD
$2.6B
$690K 0.01%
+100,000
New +$612K
QURE icon
313
uniQure
QURE
$3.03B
$688K 0.01%
60,000
+45,000
+300% +$853K
APLS
314
CALL
DELISTED
Apellis Pharmaceuticals
APLS
$638K 0.01%
+7,000
New +$604K
PTGX icon
315
Protagonist Therapeutics
PTGX
$8.79B
$624K 0.01%
+22,580
New +$565K
OXY icon
316
Occidental Petroleum
OXY
$56.8B
$617K 0.01%
10,500
-93,819
-90% -$5.63M
GDX icon
317
VanEck Gold Miners ETF
GDX
$22.7B
$602K 0.01%
20,000
-25,000
-56% -$815K
RVTY icon
318
Revvity
RVTY
$12.6B
$594K 0.01%
+5,000
New +$615K
KOD icon
319
CALL
Kodiak Sciences
KOD
$2.6B
$559K 0.01%
+81,000
New +$495K
PTGX icon
320
CALL
Protagonist Therapeutics
PTGX
$8.79B
$552K 0.01%
20,000
-5,000
-20% -$125K
ONYX
321
DELISTED
Onyx Acquisition Co. I Class A Ordinary Shares
ONYX
$541K 0.01%
50,000
– –
COOL
322
DELISTED
Corner Growth Acquisition Corp. Class A Ordinary Shares
COOL
$533K 0.01%
50,000
– –
DPCS
323
DELISTED
DP Cap Acquisition Corp I Class A Ordinary Shares
DPCS
$528K 0.01%
50,000
-50,000
-50% -$523K
VEEA
324
Veea Inc
VEEA
$8.34M
$526K 0.01%
50,000
– –
NRAC
325
DELISTED
Northern Revival Acquisition Corporation Class A Ordinary Share
NRAC
$526K 0.01%
50,000
-25,000
-33% -$259K
11 12
13
14 15

Similar funds

SIA
Sit Investment Associates Minneapolis, Minnesota $4.93B AUM 12.22% 1-Year Est. Return
FC
Freemont Capital Singapore $4.91B AUM 5.45% 1-Year Est. Return
SMFG
Sumitomo Mitsui Financial Group Tokyo, Japan $4.94B AUM 1.39% 1-Year Est. Return
KCM
Kensico Capital Management Greenwich, Connecticut $4.9B AUM 41.26% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
FFB
First Financial Bankshares Abilene, Texas $4.95B AUM 25.06% 1-Year Est. Return
CFC
Cincinnati Financial Corp Fairfield, Ohio $4.96B AUM 18.21% 1-Year Est. Return

Moore Capital Management's Q2 2023 Portfolio in Review

As of Q2 2023, Moore Capital Management held 662 positions worth $5.81B, up 22% from $4.74B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Moore Capital Management deployed $559M of net new capital in Q2 2023, opening 179 new positions and adding to 52 existing holdings. Its largest new stake was iShares MSCI Brazil ETF: 2,555,200 shares worth $82.9M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was NVIDIA, an estimated $175M trimmed.

  • Moore Capital Management's largest Q2 2023 buy was iShares MSCI Brazil ETF: 2,555,200 shares worth $82.9M.
  • Moore Capital Management added most to Amazon in Q2 2023, an estimated $156M increase.
  • Moore Capital Management's biggest Q2 2023 reduction was NVIDIA, cutting an estimated $175M.
  • Moore Capital Management fully exited Alibaba in Q2 2023, selling an estimated $223M.
  • Moore Capital Management's ten largest holdings make up 42% of its $5.81B portfolio in Q2 2023.
  • Moore Capital Management opened 179 new positions and closed 154 in Q2 2023.
  • Moore Capital Management's portfolio value rose 22% quarter-over-quarter to $5.81B.

Based on Moore Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.